These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 779909)

  • 1. Indirect and direct inhibition of dopamine beta-hydroxylase by amphetamine in storage vesicles and synaptosomes.
    Lau C; Slotkin TA
    Br J Pharmacol; 1976 Jun; 57(2):223-8. PubMed ID: 779909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of in vivo amphetamine administration on dopamine synthesis regulation in rat brain striatal synaptosomes.
    Patrick RL; Berkowitz AL; Regenstein AC
    J Pharmacol Exp Ther; 1981 Jun; 217(3):686-91. PubMed ID: 7229999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the interaction of the novel antihypertensive etamicastat with human dopamine-β-hydroxylase: comparison with nepicastat.
    Bonifácio MJ; Sousa F; Neves M; Palma N; Igreja B; Pires NM; Wright LC; Soares-da-Silva P
    Eur J Pharmacol; 2015 Mar; 751():50-8. PubMed ID: 25641750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of dopamine beta-hydroxylase by 4-hydroxypyrazole: ethanol-pyrazole effects on serum dopamine beta-hydroxylase in vivo.
    Harralson JD; Wolfe BI; Brown FC
    J Pharmacol Exp Ther; 1978 Jul; 206(1):69-74. PubMed ID: 660559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar potency ratios of amphetamine optical isomers for inhibition of dopamine uptake by synaptosomes of corpus striatum, olfactory tubercle and prefrontal cortex of the rat.
    Matthews RT; Shore PA
    Biochem Pharmacol; 1984 Sep; 33(17):2817-9. PubMed ID: 6466390
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholinergic and GABAergic regulation of dopamine beta-hydroxylase activity in the adrenal gland of the rat.
    Lima L; Sourkes TL
    J Pharmacol Exp Ther; 1986 Apr; 237(1):265-70. PubMed ID: 2937909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine and norepinephrine uptake by rat brain synaptosomes: relative inhibitory potencies of 1- and d-amphetamine and amantadine.
    Thornburg JE; Moore KE
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):81-9. PubMed ID: 4686111
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of haloperidol and d-amphetamine on cerebral tyramine and octopamine levels.
    Juorio AV; Danielson TJ
    Eur J Pharmacol; 1978 Jul; 50(1):79-82. PubMed ID: 354941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice.
    Bourdélat-Parks BN; Anderson GM; Donaldson ZR; Weiss JM; Bonsall RW; Emery MS; Liles LC; Weinshenker D
    Psychopharmacology (Berl); 2005 Nov; 183(1):72-80. PubMed ID: 16163519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyramine-binding by synaptosomes from rat brain: effect of centrally active drugs.
    Ungar F; Mosnaim AD; Ungar B; Wolf ME
    Biol Psychiatry; 1977 Oct; 12(5):661-8. PubMed ID: 588646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism-based inactivation of dopamine beta-hydroxylase by p-cresol and related alkylphenols.
    Goodhart PJ; DeWolf WE; Kruse LI
    Biochemistry; 1987 May; 26(9):2576-83. PubMed ID: 3607034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphetamine- and phenylethylamine-induced alterations in dopamine synthesis regulation in rat brain striatal synaptosomes.
    Roberts MM; Patrick RL
    J Pharmacol Exp Ther; 1979 Apr; 209(1):104-10. PubMed ID: 430370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noradrenergic role in the self-administration of morphine or amphetamine.
    Davis WM; Smith SG; Khalsa JH
    Pharmacol Biochem Behav; 1975; 3(3):477-84. PubMed ID: 168592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
    Khalsa JH; Davis WM
    J Pharmacol Exp Ther; 1977 Jul; 202(1):182-91. PubMed ID: 17725
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopamine beta-hydroxylase in health and disease.
    Rush RA; Geffen LB
    Crit Rev Clin Lab Sci; 1980; 12(3):241-77. PubMed ID: 6998654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for reversible inhibition of brain dopamine-beta-hydroxylase activity in vivo by amphetamine analogues.
    Stolk JM
    J Neurochem; 1975 Jan; 24(1):135-42. PubMed ID: 1110356
    [No Abstract]   [Full Text] [Related]  

  • 17. Is Na(+) required for the binding of dopamine, amphetamine, tyramine, and octopamine to the human dopamine transporter?
    Li LB; Cui XN; Reith MA
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):303-11. PubMed ID: 11919655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the dopamine-beta-hydroxylase inhibitor FLA 63 on the kinetics of elimination of amphetamine in the rat.
    Jonsson J; Lewander T
    J Pharm Pharmacol; 1974 Nov; 26(11):907-9. PubMed ID: 4156566
    [No Abstract]   [Full Text] [Related]  

  • 19. Interactions of amphetamine, pimozide, and lithium on plasma norepineophrine and dopamine-beta-hydroxylase in schizophrenic patients.
    Rosenblatt JE; Lake CR; van Kammen DP; Ziegler MG; Bunney WE
    Psychiatry Res; 1979 Jul; 1(1):45-52. PubMed ID: 298337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pressor responses to ephedrine are not impaired in dopamine beta-hydroxylase knockout mice.
    Liles JT; Baber SR; Deng W; Porter JR; Corll C; Murthy SN; Thomas SA; Kadowitz PJ
    Br J Pharmacol; 2007 Jan; 150(1):29-36. PubMed ID: 17099719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.